文献速递心律失常

房颤负荷与医疗利用及生活质量:CIRCA-DOSE研究

Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study.
PubMed 文献 · Eur Heart J · 2023-01-01

CIRCA-DOSE研究通过植入式心脏监测器评估346例房颤消融术后患者,发现以30秒定义的复发缺乏临床相关性;房颤发作时长>1小时或负荷>0.1%与医疗利用增加相关,时长>24小时或负荷>0.1%与生活质量受损相关。

要点

  • 以30秒定义的房颤复发缺乏临床相关性。
  • 房颤发作>1小时或负荷>0.1%与医疗利用增加相关。
  • 房颤发作>24小时或负荷>0.1%与生活质量受损相关。

核心结论

  • 以30秒房性快速性心律失常定义的复发缺乏临床相关性。
  • 房颤发作时长>1小时或负荷>0.1%与医疗利用增加相关。
  • 房颤发作时长>24小时或负荷>0.1%与疾病特异性生活质量显著受损相关。

研究设计与样本

  • CIRCA-DOSE研究评估植入式心脏监测器记录的每一次房性快速性心律失常发作的时间和时长。
  • 前瞻性收集消融术后一年的医疗利用和生活质量。

主要发现

  • 一年无复发率随心律失常时长阈值增加而升高,从52.6%(182/346)升至93.3%(323/346),P<0.0001。
  • 房颤复发限于≤1小时的患者医疗利用率与无复发患者相当。
  • 房颤复发持续>1小时的患者急诊就诊相对风险为3.2(95%CI 2.0-5.3),住院为5.3(95%CI 2.9-9.6),再次消融为27.1(95%CI 10.5-71.0)。
  • 房颤负荷≤0.1%的患者医疗利用率与无复发患者相当;负荷>0.1%的患者急诊就诊相对风险为2.4(95%CI 1.9-3.9),住院为6.8(95%CI 3.6-13.0),电复律为9.1(95%CI 3.3-25.6),再次消融为21.8(95%CI 9.2-52.2)。
  • 与无复发患者相比,房颤发作时长>24小时或负荷>0.1%时疾病特异性生活质量显著受损。

临床怎么用

  • 临床 trial 和实践中以30秒定义房颤复发可能高估临床相关复发。
  • 应关注房颤发作时长>1小时或负荷>0.1%作为医疗利用增加的预警阈值。
  • 房颤发作时长>24小时或负荷>0.1%时应评估生活质量影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Atrial tachyarrhythmia recurrence ≥30 s remains the primary endpoint of clinical trials; however, this definition has not been correlated with clinical outcomes or pathophysiological processes. This study sought to determine the atrial tachyarrhythmia duration and burden associated with meaningful clinical outcomes. METHODS AND RESULTS: The time and duration of every atrial tachyarrhythmia episode recorded on implantable cardiac monitor were evaluated. Healthcare utilization and quality of life in the year following ablation were prospectively collected. Three hundred and forty-six patients provided 126 110 monitoring days. One-year freedom from recurrence increased with arrhythmia duration thresholds, from 52.6 (182/346) to 93.3% (323/346; P < 0.0001). Patients with atrial fibrillation (AF) recurrence limited to durations ≤1 h had rates of healthcare utilization comparable with patients free of recurrence, while patients with AF recurrences lasting >1 h had a relative risk for emergency department consultation of 3.2 [95% confidence interval (CI) 2.0-5.3], hospitalization of 5.3 (95% CI 2.9-9.6), and repeat ablation of 27.1 (95% CI 10.5-71.0). Patients with AF burden of ≤0.1% had rates of healthcare utilization comparable with patients free of recurrence, while patients with AF burden of >0.1% had a relative risk for emergency department consultation of 2.4 (95% CI 1.9-3.9), hospitalization of 6.8 (95% CI 3.6-13.0), cardioversion of 9.1 (95% CI 3.3-25.6), and repeat ablation of 21.8 (95% CI 9.2-52.2). Compared with patients free of recurrence, the disease-specific quality of life was significantly impaired with AF episode durations >24 h, or AF burdens >0.1%. CONCLUSION: AF recurrence, as defined by 30 s of arrhythmia, lacks clinical relevance. AF episode durations >1 h or burdens >0.1% were associated with increased rates of healthcare utilization.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Andrade JG, Deyell MW, Macle L, et al. Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study. Eur Heart J. 2023. PMID: 36459112. doi:10.1093/eurheartj/ehac692

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。